Gong Lei, Tianjin Medical University Cancer Hospital

[ad_1]

　　Gong Lei  MD/PhD.

　　Tianjin Medical University Cancer Hospital Esophageal Oncology Deputy Chief Physician Master Instructor

　　1. Member of the Esophageal Cancer Special Committee of the Chinese Anti-Cancer Association

　　2. Member of the Digital Therapy Working Committee of the China Medical Education Association

　　3. Standing Committee Member of Translational Medicine Committee of Tianjin Society of Integrative Medicine

　　4. Standing member of the Radiotherapy Committee of Tianjin Medical and Health Society

　　5. Member of the Oncology Committee of Tianjin Medical Doctors Association

　　6. Member/Secretary of the Esophageal Cancer Special Committee of Tianjin Anti-Cancer Association

　　7. Member of the Fifth Youth Federation of Tianjin Heping District

　　8. Member of the Second Chinese Gastroenterological Surgery Elite Meeting

　　9.Young editorial board member of Chinese Journal of Clinical Oncology

　　10. Visiting Scholar at MD Anderson Cancer Center, USA

　　11. Fellowship of the European Society of Thoracic Surgery

　　12.Young innovative talents of Tianjin Medical University Cancer Hospital

　　13.Tianjin 131 third-level innovative talents

　　He is good at the surgical treatment of various types of lung cancer, esophageal cancer, and mediastinal benign and malignant tumors, especially minimally invasive surgeries such as robotic and thoracoscopic surgeries. He has rich experience in the comprehensive treatment of locally advanced lung cancer and esophageal cancer. He is also engaged in research on lung cancer metastasis and lung cancer tumor microenvironment.

　　Published as the first author and corresponding authorHe has published more than 10 SCI and other academic papers, with a cumulative impact factor of 55 points. Hosted one National Natural Youth Fund, one Wu Jieping Medical Fund, one Bethune Medical Fund, and accumulated scientific research funding of more than 500,000 yuan. Obtained Fellowship status from the European Association of Thoracic Surgery and was approved for a study abroad fund of 10,000 euros. He has won honors such as the travel award at the annual meeting of the American Thoracic Society, the travel award at the annual meeting of the Korean Anti-Cancer Association, and the second prize of the Scientific and Technological Progress Award of the Chinese Anti-Cancer Association.

[ad_2]

Source link